Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We can complain all we want about replacing the BOD

Putting it in terms that relate to our communal saga, that funding amount equates to approx 50 shareholders pitching in about 3500 shares of PTSC each at today's price. I know for many of us, that's a mere drop in the bucket of total share counts. Just thought I'd quantify it in a way that might make it more easily comparable.

I think somewhere in the past, previous letter writing efforts have indicated that those who signed on represented nearly 50M shares. If we had just one half of one percent of those shares put toward this effort, at today's prices, that would equate to $75,000 in funds. From that perspective, the risk is slight.

Share
New Message
Please login to post a reply